The DITA Pharmaceutical Content Subcommittee will define DITA topics, maps, associated metadata properties and terminology to streamline design and creation of the complete body of pharmaceutical documentation required to present a product for scientific and regulatory purposes throughout its lifecycle.
Archive - Jun 1, 2009
OASIS invites participation in new DITA Pharmaceutical Content Subcommittee
News: Submitted by carolgeyer on Mon, 2009-06-01 14:12. Last updated on Mon, 2009-06-01 14:13.